Clinical Trials on Food Allergies in Brazil

Total 141 results

Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul

Recruiting

Home-based Transcranial Direct Current Stimulation for Treatment Resistant Depression

Treatment Resistant Depression

Brazil
Philozon Geradores de Ozonio LTDA

Unknown

Clinical Trial to Evaluate the Efficacy and Safety of the Use of Ozone Versus Sunflower Oil in Treating Diabetic Foot (PHIOZO0110)

Diabetes Mellitus

Brazil
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Brain & Behavior Research...

Completed

Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial (ELECT-TDCS)

Major Depressive Disorder | Major Depressive Disorder, Recurrent, Unspecified | Major Depressive Disorder, Single Episode, Unspecified

Brazil
Hospital Santa Marcelina

Unknown

tDCS for Treatment of Depression in Parkinson's Disease

Depression | Idiopathic Parkinson Disease

Brazil
Instituto de Cardiologia do Rio Grande do Sul

Active, not recruiting

Online Psychological Support Group for Patients With Heart Failure and Depression

Depression | Heart Failure

Brazil
Universidade Federal do Rio Grande do Norte

Completed

Effectiveness of Postural Insoles Adapted in Slippers for People With Persistent Heel Pain

Metatarsalgia | Heel Pain Syndrome

Brazil
Kraepelin Psiquiatria Clinica
Eli Lilly and Company

Completed

An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache

Major Depression | Chronic Primary Headache

Brazil
Hospital de Clinicas de Porto Alegre
University of Sao Paulo; Federal University of Rio Grande do Sul

Terminated

Cannabidiol as an Adjunctive Treatment for Bipolar Depression (CBDBD)

Bipolar Disorder | Bipolar Depression | Bipolar Affective Disorder

Brazil
Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul; Hospital Moinhos de Vento

Active, not recruiting

Naturalistic Study of Ketamine in the Treatment of Depression

Bipolar Disorder | Bipolar Depression | Major Depressive Disorder | Bipolar I Disorder | Affective Disorder | Bipolar II Disorder

Brazil
Hospital de Clinicas de Porto Alegre
Federal University of Rio Grande do Sul

Active, not recruiting

From Prevention to Treatment: How Biological Rhythms Can Maintain Perinatal Mental Health

Depression, Postpartum | Anxiety State

Brazil
Federal University of São Paulo

Unknown

Effects of Transcranial Direct Current Stimulation (tDCS) on Individuals With Prader-Willi Syndrome

Depressive Disorder | Obesity | Obsessive-Compulsive Disorder | Prader-Willi Syndrome

Brazil
Universidad Internacional de Valencia
University of Guadalajara; Universidad Autonoma de Ciudad Juarez; Universidad... and other collaborators

Recruiting

Online Multi-component Psychological Intervention for Depression, Anxiety and Well-being in 7 Countries

Depression | Wellbeing | Stress | Anxiety

Brazil, Ecuador, Mexico, Netherlands, Peru, Spain
Federal University of Minas Gerais
Harvard Medical School (HMS and HSDM)

Active, not recruiting

Assessment of Sleep Quality and Mental Health After Using Meditation

Depressive Disorder | Quality of Life | Sleep Disorder | Anxiety Disorders | Insomnia | Spirituality | Stress Disorder | Insomnia Chronic | Insomnia Disorder | Complementary Therapy

Brazil
Universidade do Sul de Santa Catarina
University of Sao Paulo

Recruiting

Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic

Depression | Quality of Life | Insomnia | Anxiety | Depressive Symptoms

Brazil
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Unknown

CBT to Treat Depression in Renal Patients (CBTRPat)

Depression | End Stage Renal Disease

Brazil
Hospital do Coracao
Boehringer Ingelheim; Centro Rossi, Buenos Aires, Argentina

Recruiting

HypErsensitiVity PneumonITis: DiseAse Progression Characterization (EVITA)

Hypersensitivity Pneumonitis

Argentina, Brazil, Chile
Federal University of Pelotas

Completed

Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial (PAMELA)

Prematurity | Gestational Hypertension | Maternal Post-partum Depression | Maternal Post-partum Weight Retention | Child's Development

Brazil
Janssen-Cilag, S.A.

Completed

Treatment Resistant Depression in America Latina (TRAL)

Depressive Disorder, Treatment-Resistant

Brazil, Argentina, Mexico, Colombia
Hoffmann-La Roche

Completed

A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).

Breast Cancer

Brazil
AstraZeneca

Completed

Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression (QUALITY)

Acute Bipolar Depression

Brazil, Mexico, Peru, Turkey, Argentina, Chile, Venezuela, Colombia, Guatemala
Eli Lilly and Company

Completed

A Safety Study in Participants With Major Depressive Disorder

Depressive Disorder, Major

United States, Mexico, Spain, Brazil, Chile, Lithuania, Netherlands
Janssen Research & Development, LLC

Completed

Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants

Depressive Disorder | Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States, Belgium, Germany, Spain, Argentina, Brazil, Bulgaria
Cephalon

Completed

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Depression

United States, Argentina, Brazil, Bulgaria, Croatia, Finland, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Ukraine
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression (TRANSFORM-3)

Depressive Disorder, Treatment-Resistant

United States, France, Belgium, Spain, Poland, Bulgaria, South Africa, Finland, Brazil, Sweden, United Kingdom, Lithuania
Janssen Research & Development, LLC

Completed

Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for Suicide

Depressive Disorder, Major

United States, France, Italy, Spain, Hungary, Belgium, Brazil, Bulgaria, Poland
Cephalon

Terminated

Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Depression

United States, Argentina, Australia, Brazil, Bulgaria, Canada, Croatia, France, Germany, Hungary, Italy, Poland, Serbia, Slovakia, South Africa, Spain, Ukraine
Janssen Research & Development, LLC

Completed

A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With Seltorexant

Depressive Disorder, Major

United States, Taiwan, Czechia, Spain, Mexico, South Africa, Colombia, Russian Federation, Brazil, Bulgaria, Sweden
Janssen Research & Development, LLC

Completed

54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for Suicide (Aspire II)

Depressive Disorder, Major

United States, Belgium, Canada, Poland, France, Spain, Brazil, Lithuania, Czechia, Austria, Argentina, Turkey
Janssen-Cilag International NV

Completed

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder (ESCAPE-TRD)

Depressive Disorder, Major

Israel, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
Janssen Research & Development, LLC

Recruiting

A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD) (VENTURA-LT)

Depressive Disorder, Major

United States, Korea, Republic of, Taiwan, Slovakia, Spain, Bulgaria, Portugal, Poland, Belgium, Argentina, Czechia, Hungary, South Africa, Sweden, Italy, France, Australia, China, Brazil
AstraZeneca
Targacept Inc.

Completed

A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.

Major Depressive Disorder

Croatia, Brazil, Bulgaria, France, Poland, Russian Federation, South Africa, Hungary, Romania, Ukraine, Argentina, Chile, Slovakia, Colombia, Germany, Serbia, Spain
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression (TRANSFORM-1)

Treatment-resistant Depression

United States, France, Belgium, Mexico, Canada, Brazil, Estonia, Hungary, Slovakia
Novartis Pharmaceuticals

Terminated

Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent

Major Depressive Disorder With Suicidal Ideation With Intent

Taiwan, Spain, Germany, Netherlands, Turkey, Mexico, United States, Malaysia, Poland, Canada, Japan, Russian Federation, Argentina, Brazil
Janssen Research & Development, LLC

Completed

A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression (SUSTAIN-2)

Treatment-resistant Depression

United States, Australia, France, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Poland, Bulgaria, Malaysia, South Africa, Turkey, Finland, Korea, Republic of, Brazil, Austria, Sweden, Lithuania
Janssen Research & Development, LLC

Completed

A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression (SUSTAIN-3)

Depressive Disorder, Treatment-Resistant

United States, France, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Bulgaria, Malaysia, South Africa, Turkey, Canada, Korea, Republic of, Brazil, Estonia, Hungary, Lithuania, Slovakia, Sweden, Czechia, A... and more
Janssen Research & Development, LLC

Recruiting

A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI) (VENTURA-RWE)

Depressive Disorder, Major

United States, Korea, Republic of, Brazil, Spain, Argentina, United Kingdom, Sweden, Italy, Germany, France, Canada
Janssen Research & Development, LLC

Recruiting

A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy (VENTURA-1)

Anhedonia | Depressive Disorder, Major

United States, Spain, Bulgaria, Italy, Poland, Belgium, Argentina, Czechia, Hungary, Sweden, Brazil, Australia, Portugal
Janssen Research & Development, LLC

Recruiting

A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy (VENTURA-2)

Anhedonia | Depressive Disorder, Major

Korea, Republic of, United States, China, Taiwan, Slovakia, Brazil, Poland, Argentina, Bulgaria, Czechia, South Africa, Canada, United Kingdom, France
Janssen Research & Development, LLC

Completed

A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression (SUSTAIN-1)

Depressive Disorder, Treatment-Resistant

United States, France, Poland, Belgium, Germany, Spain, Mexico, Turkey, Canada, Brazil, Estonia, Hungary, Slovakia, Sweden, Czechia
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.

Diabetic Foot | Bacterial Infections | Osteomyelitis

China, Colombia, Estonia, Denmark, Taiwan, France, United States, Canada, Spain, Belgium, Austria, Chile, Korea, Republic of, Mexico, Slovakia, United Kingdom, Russian Federation, Croatia, Turkey, Lithuania, Poland, Latvia, Finland, H... and more
GlaxoSmithKline

Completed

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D)

Anaemia | Aspergillosis, Allergic Bronchopulmonary

Australia, Korea, Republic of, Spain, United States, Taiwan, Bulgaria, Mexico, Ukraine, Argentina, Belgium, South Africa, Singapore, Austria, Canada, Netherlands, Russian Federation, Sweden, Turkey, United Kingdom, Germany, Romania and more

Clinical Trials on Food Allergies in Brazil

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bahrain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations